Spectrum Pharmaceuticals (SPPI) Raises Buyback Plan to $100M

Article Stock Quotes (1) Comments (0)

Spectrum Pharmaceuticals (Nasdaq: SPPI) announced that the Company’s Board of Directors has approved an increase in its stock repurchase program authorizing the repurchase of up to a total of $100 million of the Company's common stock. The Company was previously authorized to repurchase up to $25 million of its stock.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Macy's (M) Posts Q1 EPS of 55c; Comps Up 3.8%; Boosts Dividend 25%, Raises Buyback
• Spectrum Pharmaceuticals to Present Corporate Update at the UBS Global Healthcare Conference in New York City on May 20th
• Ashland (ASH) Approves $600M Buyback Program

Create E-mail Alert Related Categories

Stock Buybacks

Related Entities

Stock Buyback

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?